1. Home
  2. KZIA vs CARV Comparison

KZIA vs CARV Comparison

Compare KZIA & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • CARV
  • Stock Information
  • Founded
  • KZIA 1994
  • CARV 1948
  • Country
  • KZIA Australia
  • CARV United States
  • Employees
  • KZIA N/A
  • CARV N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • CARV Savings Institutions
  • Sector
  • KZIA Health Care
  • CARV Finance
  • Exchange
  • KZIA Nasdaq
  • CARV Nasdaq
  • Market Cap
  • KZIA 6.0M
  • CARV 7.2M
  • IPO Year
  • KZIA 1999
  • CARV 1994
  • Fundamental
  • Price
  • KZIA $0.77
  • CARV $1.35
  • Analyst Decision
  • KZIA Strong Buy
  • CARV
  • Analyst Count
  • KZIA 2
  • CARV 0
  • Target Price
  • KZIA $11.50
  • CARV N/A
  • AVG Volume (30 Days)
  • KZIA 334.9K
  • CARV 12.0K
  • Earning Date
  • KZIA 04-11-2025
  • CARV 02-13-2025
  • Dividend Yield
  • KZIA N/A
  • CARV N/A
  • EPS Growth
  • KZIA N/A
  • CARV N/A
  • EPS
  • KZIA N/A
  • CARV N/A
  • Revenue
  • KZIA $1,655,324.00
  • CARV $24,056,000.00
  • Revenue This Year
  • KZIA N/A
  • CARV N/A
  • Revenue Next Year
  • KZIA N/A
  • CARV N/A
  • P/E Ratio
  • KZIA N/A
  • CARV N/A
  • Revenue Growth
  • KZIA 248000.00
  • CARV N/A
  • 52 Week Low
  • KZIA $0.76
  • CARV $1.26
  • 52 Week High
  • KZIA $15.80
  • CARV $2.39
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 35.51
  • CARV 43.22
  • Support Level
  • KZIA $0.76
  • CARV $1.37
  • Resistance Level
  • KZIA $1.05
  • CARV $1.49
  • Average True Range (ATR)
  • KZIA 0.08
  • CARV 0.09
  • MACD
  • KZIA -0.00
  • CARV 0.01
  • Stochastic Oscillator
  • KZIA 3.84
  • CARV 52.00

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: